Regulation of interleukin-12 production in human cells stimulated with Mycobacterium bovis BCG.
暂无分享,去创建一个
[1] H. Matsumoto,et al. Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells , 1997, Infection and immunity.
[2] B. Pedersen,et al. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. , 1997, Journal of immunology.
[3] W. Boom,et al. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis , 1996, Infection and immunity.
[4] S. Holland,et al. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. , 1996, Journal of immunology.
[5] P. Linsley,et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.
[6] C. Marsh,et al. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. , 1996, Journal of immunology.
[7] J. Flynn,et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.
[8] R. Appelberg,et al. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. , 1995, Journal of immunology.
[9] C S Berkey,et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.
[10] Alan D. Roberts,et al. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. , 1995, Immunology.
[11] D E Snider,et al. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.
[12] H. Shiratsuchi,et al. Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis , 1995, Infection and immunity.
[13] H. Shiratsuchi,et al. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.
[14] M. Feldmann,et al. Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes , 1994, European journal of immunology.
[15] R. Wallis,et al. Cytokines and tuberculosis , 1994, Journal of leukocyte biology.
[16] M. Gately,et al. Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.
[17] F. Mosteller,et al. Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature , 1994 .
[18] V. Diwan,et al. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. , 1993, International journal of epidemiology.
[19] G. Trinchieri,et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.
[20] G. Trinchieri,et al. Interleukin-12 and its role in the generation of TH1 cells. , 1993, Immunology today.
[21] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[22] M. Bertagnolli,et al. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. , 1992, Journal of immunology.
[23] Giorgio,et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.
[24] Christopher J. L. Murray,et al. Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.
[25] A. Sher,et al. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.
[26] A. Sher,et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.
[27] Y. Vodovotz,et al. Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.
[28] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[29] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[30] C. Figdor,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.
[31] M. Turner,et al. Modulation of cytokine production by transforming growth factor-beta. , 1989, Journal of immunology.
[32] V. Ferrans,et al. Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide. , 1988, Journal of immunology.
[33] J. Steer,et al. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. , 1996, Cytokine.